Novartis AG Common Stock (NVS)
R&D to Revenue
19.14%
Quarterly · Period ending:
NVS R&D to Revenue
Latest reported19.14%period ending
Latest reported19.14%period ending
NVS Quarterly R&D/Revenue (0.00% → 19.14%)
Latest values, visible window
High-resolution chart · PNG
NVS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 12.99% | |
| 0% | |
| 0% | |
| 0% | |
| 13.3941% | |
| 0% |